Nalaganje...

The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade in Solid Malignancies

There have been unprecedented advances in the treatment of cancer through the use of immunotherapy, with several agents now FDA-approved for use in widespread metastatic disease across cancer types. Immune checkpoint blockade represents a particularly promising class of agents that block inhibitory...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Surg Oncol
Main Authors: Keung, Emily Z., Ukponmwan, Esosa U., Cogdill, Alex, Wargo, Jennifer A.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6105272/
https://ncbi.nlm.nih.gov/pubmed/29500764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-018-6379-8
Oznake: Označite
Brez oznak, prvi označite!